MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517057637 A) filed by University Of Cape Town, Cape Town, South Africa, on June 16, for 'phenyl-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivates for use as 5-alpha reductase antagonists in methods of treatment.'
Inventor(s) include Arowolo, Afolake; Khumalo, Nonhlanhla Patience; Oputu, Ogheneochuko Utieyin; Ntshingila, Sincengile Nokubonga; and Fienberg, Stephen.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides for compounds that are phenyl-pyrazolo[3,4- b]pyridine-4-carboxylic acid derivates for use as 5-alpha reductase antagonists, in particular as type 1 and type 2 antagonists. The invention further provides for pharmaceutical compositions comprising these compounds, and the use of these compounds and compositions in the treatment of diseases or disorders, in particular but not exclusively, in the treatment of benign prostatic hyperplasia and androgenetic alopecia."
The patent application was internationally filed on Dec. 06, 2023, under International application No.PCT/IB2023/062307.
Disclaimer: Curated by HT Syndication.
